This study is designed to better understand the long-term effects of hyperbaric oxygen therapy (HBOT). Our goal is to determine whether improvements after treatment are maintained over time and whether additional benefits appear months after treatment has ended. We will evaluate changes in cognitive function, mental health, and daily functioning to help strengthen the scientific evidence supporting the use of HBOT and guide future treatment recommendations.
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
NeuroTrax
Timeframe: Baseline (post-HBOT completion) and 12 weeks after the final HBOT session
PTSD Checklist for DSM-5 (PCL-5)
Timeframe: Baseline (post-HBOT completion) and 12 weeks after the final HBOT session
Patient Health Questionnaire-9 (PHQ-9)
Timeframe: Baseline (post-HBOT completion) and 12 weeks after the final HBOT session
Generalized Anxiety Disorder 7-item scale (GAD-7)
Timeframe: Baseline (post-HBOT completion) and 12 weeks after the final HBOT session
World Health Organization Quality of Life (WHOQOL-BREF)
Timeframe: Baseline (post-HBOT completion) and 12 weeks after the final HBOT session